Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection

Pediatrics

Volumn 123, Issue 3, 2009, Pages 935-943

  Butler, Anne M ^a   Williams, Paige L ^b,c   Howland, Lois C ^c   Storm, Deborah ^d   Hutton, Nancy ^e   Seage, George R ^b,f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF SAN DIEGO   (United States)

^e The State University of New Jersey   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children and adolescents; HIV; Quality of life

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CAREGIVER; CHILD; CONTROLLED STUDY; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; PHYSICAL MOBILITY; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SCHOOL CHILD; SOCIAL INTERACTION; ADOLESCENT; AGE; AWARENESS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE TRANSMISSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; LONGITUDINAL STUDY; MALE; PATIENT ATTITUDE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SOCIAL ADAPTATION; VIRUS LOAD;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; AGE FACTORS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AWARENESS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SICK ROLE; SOCIAL ADJUSTMENT; VIRAL LOAD;

EID: 63149180620     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1290     Document Type: Article

References (41)

1. Berk DR, Falkovitz-Halpern MS, Hill DW, et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA. 2005;293(18):2221-2231
2. Wiener L, Lyon M. HIV disclosure: who knows? who needs to know?: clinical and ethical considerations. In: Lyon M, D'Angelo L, eds. Teenagers, HIV, and AIDS: Insights From Youths Living With the Virus. Westport, CT: Praeger Publishers; 2006: 105-126
3. Patel K, Hernan MA, Williams PL, et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis. 2008;46(4):507-515
4. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection: Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284(2):190-197
5. Lester P, Chesney M, Cooke M, et al. When the time comes to talk about HIV: factors associated with diagnostic disclosure and emotional distress in HIV-infected children. J Acquir Immune Defic Syndr. 2002;31(3):309-317
6. Instone SL. Perceptions of children with HIV infection when not told for so long: implications for diagnosis disclosure. J Pediatr Health Care. 2000;14(5):235-243
7. Bachanas PJ, Kullgren KA, Schwartz KS, et al. Predictors of psychological adjustment in school-age children infected with HIV. J Pediatr Psychol. 2001;26(6):343-352
8. American Academy of Pediatrics Committee on Pediatrics AIDS. Disclosure of illness status to children and adolescents with HIV infection. Pediatrics. 1999;103(1):164-166
9. Lee CL, Johann-Liang R. Disclosure of the diagnosis of HIV/ AIDS to children born of HIV-infected mothers. AIDS Patient Care STDS. 1999;13(1):41-45
10. Lester P, Chesney M, Cooke M. Diagnostic disclosure to HIV-infected children: how parents decide when and what to tell. Clin Child Psychol Psychiatry. 2002;7:85-99
11. Steele RG, Nelson TD, Cole BP. Psychosocial functioning of children with AIDS and HIV infection: review of the literature from a socioecological framework. J Dev Behav Pediatr. 2007; 28(1):58-69
12. Thorne C, Newell ML, Peckham CS. Disclosure of diagnosis and planning for the future in HIV-affected families in Europe. Child Care Health Dev. 2000;26(1):29-40
13. Thorne C, Newell ML, Botet FA, et al. Older children and adolescents surviving with vertically acquired HIV infection. J Acquir Immune Defic Syndr. 2002;29(4):396-401
14. Brady MT, Clark C, Weedy C, Fowler M, Mofenson L, Oleske J. Disclosure of HIV diagnosis to children in ACTG clinical trials (ACTG 219) (Poster We.D. 131). Presented at the XI International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia
15. Grubman S, Gross E, Lerner-Weiss N, et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics. 1995;95(5):657-663
16. Lipson M. Disclosure of diagnosis to children with human immunodeficiency virus or acquired immunodeficiency syndrome. J Dev Behav Pediatr. 1994;15(3 suppl):S61-S65
17. Mellins CA, Brackis-Cott E, Dolezal C, Richards A, Nichols SW, Abrams EJ. Patterns of HIV status disclosure to perinatally HIV-infected children and subsequent mental health outcomes. Clin Child Psychol Psychiatry. 2002;7(1):101-114
18. Slavin LA, O'Malley JE, Koocher GP, Foster DJ. Communication of the cancer diagnosis to pediatric patients: impact on long-term adjustment. Am J Psychiatry. 1982;139(2):179-183
19. Spinetta J, Maloney J. Death anxiety in the outpatient leukemic child. Pediatrics. 1975;56(6):1035-1037
20. Van Dongen-Melman JE, Sanders-Woudstra JA. Psychosocial aspects of childhood cancer: a review of the literature. J Child Psychol Psychiatry. 1986;27(2):145-180
21. Claflin CJ, Barbarin OA. Does "telling" less protect more?: relationships among age, information disclosure, and what children with cancer see and feel. J Pediatr Psychol. 1991;16(2): 169-191
22. Wiener LS, Battles HB, Heilman N, Sigelman CK, Pizzo PA. Factors associated with disclosure of diagnosis to children with HIV/AIDS. Pediatr AIDS HIV Infect. 1996;7(5):310-324
23. Wiener L, Mellins CA, Marhefka S, Battles HB. Disclosure of an HIV diagnosis to children: history, current research, and future directions. J Dev Behav Pediatr. 2007;28(2):155-166
24. Gortmaker S, Lenderking WR, Clark C, Lee S, Fowler MG, Oleske JM. Development and use of a pediatric quality of life questionnaire in AIDS clinical trials: reliability and validity of the General Health Assessment for Children (GHAC). In: Drotar D, ed. Assessing Pediatric Health-Related Quality of Life and Functional Status: Implications for Research, Practice and Policy. Mahwah, NJ: Lawrence Feldbaum, Associates; 1998:219-235
25. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273(1):59-65
26. Testa MA, Lenderking WR. Quality of life considerations in AIDS clinical trials. In: Finkelstein DM, Schoenfeld DA, eds. AIDS Clinical Trials. New York, NY: Wiley-Liss; 1992:213-241
27. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19
28. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Recomm Rep. 1994;43(RR-12):1-10
29. Howland LC, Storm DS, Gortmaker SL, Crawford SL, Ma Y, Oleske JM. Negative life events: risk to health-related quality of life in children and youth with HIV Infection. J Assoc Nurses AIDS Care. 2007;18(1):3-11
30. Storm DS, Boland MG, Gortmaker SL, et al. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection. Pediatrics. 2005;115(2). Available at: www.pediatrics.org/cgi/content/full/115/2/e173
31. Lee GM, Gortmaker SL, McIntosh K, Hughes MD, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219C Team. Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment. Pediatrics. 2006;117(2):273-283
32. Gaughan DM, Hughes MD, Seage GR III, et al. The prevalence of pain in pediatric human immunodeficiency virus/acquired immunodeficiency syndrome as reported by participants in the Pediatric Late Outcomes Study (PACTG 219). Pediatrics. 2002; 109(6):1144-1152
33. Patrick DL, Erickson P. Health Status and Health Policy: Allocating Resources to Health Care. New York, NY: Oxford University Press; 1993
34. Little RJA, Rubin DB. Statistical Analysis With Missing Data. 2nd ed. New York, NY: John Wiley & Sons; 2002
35. Zimmerman M. Weighted versus unweighted life event scores: is there a difference? J Human Stress. 1983;9(4):30-35
36. Walker G. In the Midst of Winter. New York, NY: Norton; 1991
37. Blasini I, Chantry C, Cruz C, et al. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr. 2004;25(3):181-189
38. Riekert KA, Wiener L, Battles HB. Prediction of psychological distress in school-age children with HIV. Child Health Care. 1999;28(3):201-220
39. Ng WYK, Mellins CA, Ryan S. The mental health treatment of children and adolescents perinatally infected with HIV. Abrams E, ed. Topic of the Month. 2004. 2-1-0008. Available at: www.archive.org/web/20040419162219/ hivfiles.org/topic.html. Accessed February 1, 2008
40. Brunner HI, Klein-Gitelman MS, Miller MJ, et al. Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum. 2004;51(5):763-773
41. Chang PC, Yeh CH. Agreement between child self-report and parent proxy-report to evaluate quality of life in children with cancer. Psychooncology. 2005;14(2):125-134